Role of G protein-coupled estrogen receptor 1 in modulating transforming growth factor-β stimulated mesangial cell extracellular matrix synthesis and migration

Molecular and Cellular Endocrinology

Volumn 391, Issue 1-2, 2014, Pages 50-59

  Li, Yi Chen ^a,b   Ding, Xuan Sheng ^b   Li, Hui Mei ^b   Zhang, Ying ^b   Bao, Jing ^b  

^a THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Cell migration; Estrogen receptor; Extracellular matrix; G protein coupled estrogen receptor 1; Mesangial cell

Indexed keywords

COLLAGEN TYPE 4; ESTRADIOL; FIBRONECTIN; FULVESTRANT; G PROTEIN COUPLED RECEPTOR 30; PROTEASOME; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; UBIQUITIN; 1,3 BENZODIOXOLE DERIVATIVE; 4-(6-BROMO-1,3-BENZODIOXOL-5-YL)-3A,4,5,9B-3H-CYCLOPENTA(C)QUINOLINE; G PROTEIN COUPLED RECEPTOR; GPR30 PROTEIN, RAT; MADH2 PROTEIN, RAT; MADH3 PROTEIN, RAT; MADH4 PROTEIN, RAT; QUINOLINE DERIVATIVE; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; EXTRACELLULAR MATRIX; FIBRONECTIN GENE; GPER GENE; HUMAN; HUMAN CELL; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; AGONISTS; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL MOTION; CYTOLOGY; DOSE RESPONSE; DRUG EFFECTS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PRIMARY CELL CULTURE; SPRAGUE DAWLEY RAT;

ANIMALS; BENZODIOXOLES; CELL MOVEMENT; COLLAGEN TYPE IV; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; EXTRACELLULAR MATRIX; FEMALE; FIBRONECTINS; GENE EXPRESSION REGULATION; HUMANS; MESANGIAL CELLS; PRIMARY CELL CULTURE; PROTEASOME ENDOPEPTIDASE COMPLEX; QUINOLINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, G-PROTEIN-COUPLED; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84900021197     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2014.04.014     Document Type: Article

References (36)

1. Abboud H.E. Mesangial cell biology. Exp. Cell Res. 2012, 318:979-985.
2. Abdollah S., Macias-Silva M., Tsukazaki T., Hayashi H., Attisano L., Wrana J.L. TβRI phosphorylation of Smad2 on Ser465 and Ser467 is required for Smad2-Smad4 complex formation and signalling. J. Biol. Chem. 1997, 272:27678-27685.
3. Addo S., Yates R.A., Laight A. A phase I trial to assess the pharmacology of the new oestrogen receptor antagonist fulvestrant on the endometrium in healthy postmenopausal volunteers. Brit. J. Cancer 2002, 87:1354-1359.
4. Band A.M., Laiho M. Crosstalk of TGF-β and estrogen receptor signaling in breast cancer. J. Mammary Gland Biol. Neoplasia 2011, 16:109-115.
5. Biederman J., Yee J., Cortes P. Validation of internal control genes for gene expression analysis in diabetic glomerulosclerosis. Kidney Int. 2004, 66:2308-2314.
6. Chen Y., Blom I.E., Sa S., Goldschmeding R., Abraham D.J., Leask A. CTGF expression in mesangial cells: involvement of SMADs, MAP kinase, and PKC. Kidney Int. 2002, 62:1149-1159.
7. Crean J.K.G., Finlay D., Murphy M., Moss C., Godson C., Martin F., Brady H.R. The role of p42/44 MAPK and protein kinase B in connective tissue growth factor induced extracellular matrix protein production, cell migration, and actin cytoskeletal rearrangement in human mesangial cells. J. Biol. Chem. 2002, 46:44187-44194.
8. Dennis M.K., Burai R., Ramesh C., Petrie W.K., Alcon S.N., Nayak T., Bologa C., Leitao A., Brailoiu E., Deliu E., Dun N.J., Sklar L.A., Hathaway H.J., Arterburn J.B., Oprea T.O., Prossnitz E.R. In vivo effects of a GPR30 antagonist. Nat. Chem. Biol. 2009, 5(6):421-427.
9. Dixon A., Maric C. 17β-Estradiol attenuates diabetic kidney disease by regulating extracellular matrix and transforming growth factor-β protein expression and signaling. Am. J. Physiol. Renal Physiol. 2007, 293:F1678-F1690.
10. Eisel F., Boosen M., Beck M., Heide H., Wittig I., Beck K.F., Josef P. Platelet-derived growth factor triggers PKA-mediated signalling by a redox-dependent mechanism in rat renal mesangial cells. Biochem. Pharmacol. 2013, 85:101-108.
11. Eriksen B.O., Ingebretsen O.C. The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age. Kidney Int. 2006, 69:375-382.
12. Fliardo E.J., Quinn J.A., Frackelton A.R., Bland K.I. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Mol. Endocrinol. 2002, 16:70-84.
13. Gros R., Ding Q., Liu B., Chorazyczewski J., Feldman R.D. Aldosterone mediates its rapid effects in vascular endothelial cells through GPER activation. Am. J. Physiol. Cell Physiol. 2013, 304:C532-C540.
14. Ito I., Hanyu A., Wayama M., Goto N., Katsuno Y., Kawasaki S., Nakajima Y., Kajiro M., Komatsu Y., Fujimura A., Hirota R., Murayama A., Kimura K., Imamura T., Yanagisawa J. Estrogen inhibits transforming growth factor β signaling by promoting Smad2/3 degradation. J. Biol. Chem. 2010, 285(19):14747-14755.
15. Kleuser B., Malek D., Gust R., Pertz H.H., Potteck H. 17-β-Estradiol inhibits transforming growth factor-β signalling and function in breast cancer cells via activation of extracellular signal-regulated kinase through the G protein-coupled receptor 30. Mol. Pharmacol. 2008, 74:1533-1543.
16. Krepinsky J., Ingram A.J., James L., Ly H., Thai K., Cattran D.C., Miller J.A., Scholey J.W. 17β-Estradiol modulates mechanical strain-induced MAPK activation in mesangial cells. J. Biol. Chem. 2002, 277:9387-9394.
17. Kwan G., Neugarten J., Sherman M., Ding Q., Fotadar U., Lei J., Silbiger S. Effects of sex hormones on mesangial cell proliferation and collagen synthesis. Kidney Int. 1996, 50:1173-1179.
18. Li Y.C., Ding X.S., Li H.M., Zhang C. Icariin attenuates high glucose-induced type IV collagen and fibronectin accumulation in glomerular mesangial cells by inhibiting transforming growth factor-β production and signalling through G protein-coupled oestrogen receptor 1. Clin. Exp. Pharmacol. Physiol. 2013, 40:635-643.
19. Mankhey R.W., Bhatti F., Maric C. 17β-Estradiol replacement improves renal function and pathology associated with diabetic nephropathy. Am. J. Physiol. Renal Physiol. 2005, 288:F399-F405.
20. Martin J., Eynstone L.V., Davies M., Williams J.D., Steadman R. The role of ADAM 15 in glomerular mesangial cell migration. J. Biol. Chem. 2002, 277:33683-33689.
21. Matsuda T., Yamamoto T., Muraguchi A., Saatcioglu F. Cross-talk between transforming growth factor-β and estrogen receptor signaling through Smad3. J. Biol. Chem. 2001, 276(46):42908-42914.
22. Neugarten J., Acharya A., Lei J., Silbiger S. Selective estrogen receptor modulators suppress mesangial cell collagen synthesis. Am. J. Physiol. Renal Physiol. 2000, 279:F309-F318.
23. Neugarten J., Acharya A., Silbiger S.R. Effect of gender on the progression of nondiabetic renal disease: a meta-analysis. J. Am. Soc. Nephrol. 2000, 11:319-329.
24. Nilsson S., Makela S., Treuter E., Tujague M., Thomsen J., Andersson G., Enmark E., Pettersson K., Warner M., Gustafsson J.A. Mechanism of estrogen action. Physiol. Rev. 2001, 81(4):1535-1565.
25. Prossnitz E.R., Barton M. The G-protein-coupled estrogen receptor GPER in health and disease. Nat. Rev. Endocrinol. 2011, 7:715-726.
26. Prossnitz, E.R., Barton, M., 2014. Estrogen biology: new insights into GPER function and clinical opportunities. Mol. Cell. Endocrinol. [Epub ahead of print]. <>. http://www.dx.doi.org/10.1016/j.mce.2014.02.002.
27. Riser B.L., Cortes P., Yee J., Sharba A.K., Asano K., Rodriguez-Barbero A., Narins R.G. Mechanical strain- and high glucose-induced alterations in mesangial cell collagen metabolism: role of TGF-β. J. Am. Soc. Nephrol. 1998, 9:827-836.
28. Robertson J.F.R. Fulvestrant (Faslodex®) - how to make a good drug better. Oncologist 2007, 12:774-784.
29. Robertson J.F.R., Harrison M. Fulvestrant: pharmacokinetics and pharmacology. Brit. J. Cancer 2004, 90:S7-S10.
30. Silbiger S., Neugarten J. Gender and human chronic renal disease. Gender Med. 2008, 5:S3-S10.
31. Silbiger S., Lei J., Ziyadeh F.N., Neugarten J. Estradiol reverses TGF-b1-stimulated type IV collagen gene transcription in murine mesangial cells. Am. J. Physiol. Renal Physiol. 1998, 274:F1113-F1118.
32. Silbiger S., Lei J., Neugarten J. Estradiol suppresses type I collagen synthesis in mesangial cells via activation of activator protein-1. Kidney Int. 1999, 55:1268-1276.
33. Sraer J.D., Delarue F., Hagege J., Feunteun J., Pinet F., Nguyen G., Rondeau E. Stable cell lines of T-SV40 immortalized human glomerular mesangial cells. Kidney Int. 1996, 49:267-270.
34. Thomas P., Pang Y., Filardo E.J., Dong J. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 2005, 146(2):624-632.
35. Wada J., Makino H., Kanwar Y.S. Gene expression and identification of gene therapy targets in diabetic nephropathy. Kidney Int. 2002, 61:S73-S78.
36. Weston B.S., Wahab N.A., Mason R.M. CTGF mediates TGF-β-induced fibronectin matrix deposition by upregulating active α5β1 integrin in human mesangial cells. J. Am. Soc. Nephol. 2003, 14:601-610.